Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
Tessier E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, Plouzeau-Jayle C, Chenouard R, Guérin F, Tandé D, Lamoureux C, Bémer P, Corvec S; CRIOGO study group. Tessier E, et al. J Antimicrob Chemother. 2024 May 2;79(5):1045-1050. doi: 10.1093/jac/dkae071. J Antimicrob Chemother. 2024. PMID: 38507272
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
Hervochon C, Hennart B, Leroy AG, Corvec S, Boutoille D, Senneville É, Sotto A, Illes G, Chavanet P, Dubée V, Bleibtreu A, De Carné MC, Talarmin JP, Revest M, Castan B, Bellouard R, Dailly É, Allorge D, Dinh A, Le Turnier P, Gregoire M; Dalbavancin Pharmacokinetics (DALBAP) study group. Hervochon C, et al. J Antimicrob Chemother. 2023 Dec 1;78(12):2919-2925. doi: 10.1093/jac/dkad331. J Antimicrob Chemother. 2023. PMID: 37864551
Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales.
Davido B, Crémieux AC, Nich C, De Truchis P, Vaugier I, Gatin L, Tattevin P, Saleh-Mghir A. Davido B, et al. Among authors: nich c. Int J Antimicrob Agents. 2023 Dec;62(6):107003. doi: 10.1016/j.ijantimicag.2023.107003. Epub 2023 Oct 14. Int J Antimicrob Agents. 2023. PMID: 37839717 Free article.
Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment.
MacLean RR, Ankawi B, Driscoll MA, Gordon MA, Frankforter TL, Nich C, Szollosy SK, Loya JM, Brito L, Ribeiro MIP, Edmond SN, Becker WC, Martino S, Sofuoglu M, Heapy AA. MacLean RR, et al. Among authors: nich c. JMIR Res Protoc. 2024 Mar 20;13:e54342. doi: 10.2196/54342. JMIR Res Protoc. 2024. PMID: 38506917 Free PMC article.
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population.
Edelman EJ, Rojas-Perez OF, Nich C, Corvino J, Frankforter T, Gordon D, Jordan A, Paris M Jr, Weimer MB, Yates BT, Williams EC, Kiluk BD. Edelman EJ, et al. Among authors: nich c. Addict Sci Clin Pract. 2023 Sep 19;18(1):55. doi: 10.1186/s13722-023-00407-9. Addict Sci Clin Pract. 2023. PMID: 37726823 Free PMC article.
Breaking through social determinants of health: Results from a feasibility study of Imani Breakthrough, a community developed substance use intervention for Black and Latinx people.
Jordan A, Costa M, Nich C, Swarbrick M, Babuscio T, Wyatt J, O'Connell M, Guy K, Blackman K, Anderson RR, Reis G, Ocasio L, Crespo M, Bellamy C. Jordan A, et al. Among authors: nich c. J Subst Use Addict Treat. 2023 Oct;153:209057. doi: 10.1016/j.josat.2023.209057. Epub 2023 May 18. J Subst Use Addict Treat. 2023. PMID: 37207836
179 results